11-36493896-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004620.4(TRAF6):​c.678+1080T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.115 in 152,276 control chromosomes in the GnomAD database, including 1,147 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.12 ( 1147 hom., cov: 32)

Consequence

TRAF6
NM_004620.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.83

Publications

5 publications found
Variant links:
Genes affected
TRAF6 (HGNC:12036): (TNF receptor associated factor 6) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain and mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. The protein encoded by this gene is a key molecule in antiviral innate and antigen-specific immune responses. [provided by RefSeq, Nov 2021]
TRAF6 Gene-Disease associations (from GenCC):
  • autosomal dominant hypohidrotic ectodermal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.142 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004620.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF6
NM_004620.4
MANE Select
c.678+1080T>C
intron
N/ANP_004611.1
TRAF6
NM_145803.3
c.678+1080T>C
intron
N/ANP_665802.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF6
ENST00000526995.6
TSL:1 MANE Select
c.678+1080T>C
intron
N/AENSP00000433623.1
TRAF6
ENST00000348124.5
TSL:1
c.678+1080T>C
intron
N/AENSP00000337853.5
TRAF6
ENST00000529150.1
TSL:5
n.223+1080T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.115
AC:
17526
AN:
152158
Hom.:
1146
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0693
Gnomad AMI
AF:
0.0351
Gnomad AMR
AF:
0.0858
Gnomad ASJ
AF:
0.160
Gnomad EAS
AF:
0.0521
Gnomad SAS
AF:
0.150
Gnomad FIN
AF:
0.173
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.142
Gnomad OTH
AF:
0.123
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.115
AC:
17528
AN:
152276
Hom.:
1147
Cov.:
32
AF XY:
0.115
AC XY:
8559
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0692
AC:
2876
AN:
41580
American (AMR)
AF:
0.0857
AC:
1310
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.160
AC:
557
AN:
3472
East Asian (EAS)
AF:
0.0520
AC:
270
AN:
5188
South Asian (SAS)
AF:
0.151
AC:
727
AN:
4826
European-Finnish (FIN)
AF:
0.173
AC:
1831
AN:
10588
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.142
AC:
9633
AN:
68010
Other (OTH)
AF:
0.123
AC:
259
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
796
1591
2387
3182
3978
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.131
Hom.:
193
Bravo
AF:
0.105
Asia WGS
AF:
0.101
AC:
350
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
11
DANN
Benign
0.74
PhyloP100
2.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030470; hg19: chr11-36515446; API